Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

Publisher： Bentham Science Publishers

ISSN： 2212-697X

Source： Clinical Cancer Drugs, Vol.2, Iss.1, 2015-05, pp. : 54-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 1, 2015-05 ,pp. : 54-60

Bentham Science Publishers

Access to resources Recommend Favorite

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 112-118

Bentham Science Publishers

Access to resources Recommend Favorite

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 112-118

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma

By  

Journal of Digestive Diseases, Vol. 16, Iss. 9, 2015-09 ,pp. : 505-512

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score‐based weighting

By  

Journal of Digestive Diseases, Vol. 16, Iss. 3, 2015-03 ,pp. : 143-151

John Wiley & Sons Inc

Access to resources Recommend Favorite